info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

Thyroid Eye Disease Market By Product Type (Biologic Therapies, Corticosteroids, Immunomodulatory Therapies, Orbital Decompression Surgery, Strabismus Surgery, Eyelid Surgery); By Application (Active Moderate-to-Severe Thyroid Eye Disease, Chronic or Inactive Thyroid Eye Disease, Sight-Threatening Thyroid Eye Disease, Residual Proptosis, Diplopia and Eyelid Dysfunction); By End User (Hospitals, Specialty Ophthalmology and Endocrinology Clinics, Infusion Centres, Ambulatory Surgical Centres); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Thyroid Eye Disease Market: Biologic Competition Reshapes a Combined Drug-and-Surgery Treatment Pathway

The Global Thyroid Eye Disease Market was valued at USD 2.90 billion in 2025 and is projected to reach USD 4.81 billion by 2032, expanding at a CAGR of 7.5% during ... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Antivirulence Therapeutics Market By Therapeutic Type (Toxin-Neutralising Agents, Anti-Biofilm Agents, Quorum-Sensing Inhibitors, Adhesion Inhibitors, Secretion-System Inhibitors); By Target Pathogen (Bacillus anthracis, Clostridioides difficile, Pseudomonas aeruginosa, Staphylococcus aureus, Other Bacterial Pathogens); By Application (Inhalational Anthrax, Botulism, Recurrent Clostridioides difficile Infection, Cystic Fibrosis and Bronchiectasis, Hospital-Acquired and Ventilator-Associated Pneumonia, Implant-Associated and Chronic Wound Infections, Other Bacterial Infections); By End User (Hospitals and Intensive Care Units, Specialty Respiratory and Infectious Disease Clinics, Government Biodefence and Public Health Agencies, Academic and Clinical Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Antivirulence Therapeutics Market: Next-Generation Pathogen Disarmament and the Future of Precision Anti-Infective Innovation

The Global Antivirulence Therapeutics Market was valued at USD 1.38 billion in 2025 and is projected to reach USD 3.72 billion by 2032, expand... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Batten Disease Treatment Market By Treatment Type (Enzyme Replacement Therapy, Antiseizure Medications, Symptomatic and Supportive Therapy, Gene Therapy and Other Investigational Treatments), By Disease Type (CLN1 Disease, CLN2 Disease, CLN3 Disease, CLN5 Disease, CLN6 Disease, CLN7 Disease, CLN8 Disease, Other Neuronal Ceroid Lipofuscinosis Types), By Route of Administration (Intracerebroventricular, Oral, Intravenous, Other Routes), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Other Distribution Channels), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Batten Disease Treatment Market: A High-Value CLN2 Therapy Anchors a Wider Supportive-Care Market

The Global Batten Disease Treatment Market was valued at USD 0.21 billion in 2025 and is projected to reach USD 0.55 billion by 2032, expanding at a CAGR of 14.7% during ... Read More

Published Date: JUL-2026 | No Of Pages:160 | $ 4485

Ataxia Market By Product/Service (Pharmaceutical Therapies, Diagnostic and Monitoring Services, Rehabilitation Services, Assistive and Communication Devices); By Application (Friedreich Ataxia, Spinocerebellar Ataxias, Other Hereditary Ataxias, Sporadic and Idiopathic Progressive Ataxias); By End User (Hospitals and Specialist Neurology Centres, Rehabilitation Centres, Diagnostic Laboratories, Specialty Pharmacies and Homecare Providers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Ataxia Market: Supportive-Care Scale Meets the Rise of Precision Neurology

The Global Ataxia Market was valued at USD 1.05 billion in 2025 and is projected to reach USD 2.25 billion by 2032, expanding at a CAGR of... Read More

Published Date: JUL-2026 | No Of Pages:192 | $ 4485

Myelofibrosis Treatment Market By Product Type (Ruxolitinib, Fedratinib, Pacritinib, Momelotinib, Other and Emerging Therapies); By Treatment Application (Anaemic Myelofibrosis, Severe Thrombocytopenic Myelofibrosis, JAK-Inhibitor-Naïve Myelofibrosis, Relapsed or Refractory Myelofibrosis); By End User (Hospitals, Haematology and Oncology Clinics, Specialty Treatment Centres, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Myelofibrosis Treatment Market: Cytopenia-Focused Therapies Reshape Revenue, Competition and Patient Access

The Global Myelofibrosis Treatment Market was valued at USD 3.45 billion in 2025 and is to reach USD 6.03 billion by&nbs... Read More

Published Date: JUL-2026 | No Of Pages:188 | $ 4485

Keloid Treatment Market By Treatment Type (Intralesional Corticosteroids, Silicone Gel Sheets, Cryotherapy, Laser Therapy, Surgical Excision, Radiation Therapy, Combination Therapies, Other Adjunctive Treatments), By Keloid Location (Ear and Earlobe, Chest, Shoulders and Upper Back, Face and Neck, Other Body Areas), By End User (Hospitals, Dermatology Clinics, Plastic Surgery and Aesthetic Clinics, Radiation Oncology Centers), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Keloid Treatment Market: Combination Care, Recurrence Control, and Expanding Specialist Demand

The Global Keloid Treatment Market was valued at USD 4.25 billion in 2025 and is projected to reach USD 5.79 billion by 2032, expanding at a CAGR of 4.5% during 2026–2... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Meningitis Treatment Market By Product (Antibiotics, Antifungal Drugs, Antiviral Drugs, Adjunctive Corticosteroids, Immunosuppressive and Oncology-Directed Therapies, Supportive Care Medicines), By Application (Bacterial Meningitis, Viral Meningitis, Fungal Meningitis, Parasitic Meningitis, Non-Infectious Meningitis), By End User (Hospitals and Intensive Care Units, Infectious Disease and HIV Treatment Centers, Oncology and Neurology Centers, Government and Public Health Programs), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Meningitis Treatment Market: From Emergency Intervention to Improved Hospital Care

The Global Meningitis Treatment Market was valued at USD 0.17 billion in 2025 and is projected to reach USD 0.227 billion by 2032, expanding at a CAGR of 4.2% during 2026&ndas... Read More

Published Date: JUL-2026 | No Of Pages:170 | $ 4485

Sleep Bruxism Treatment Market By Treatment Type (Dental Appliances, Botulinum Toxin Injections, Pharmacological Therapies, Behavioral Therapies, Physical Therapies), By Dental Appliance Type (Custom Stabilization Splints/Night Guards, Mandibular Advancement Devices, Over-the-Counter Mouth Guards, Digitally Manufactured Night Guards), By End User (Dental Clinics, Hospitals and Sleep Centers, Specialty Clinics, Physiotherapy and Behavioral Care Centers, Homecare Settings), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Sleeping Bruxism Treatment Market: From Nighttime Grinding to a Growing Preventive-Care Economy

The Global Sleep Bruxism Treatment Market was valued at USD 590 million in 2025 and is projected to reach USD 923 million by 2032, expanding at a CAGR of 6.6% during 2... Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

PD-1 and PD-L1 Inhibitors Market By Inhibitor Type (PD-1 Inhibitors, PD-L1 Inhibitors); By Drug (Pembrolizumab, Nivolumab, Atezolizumab, Durvalumab, Avelumab, Cemiplimab, Dostarlimab, Toripalimab, Other PD-1 and PD-L1 Inhibitors); By Route of Administration (Intravenous, Subcutaneous); By Application (Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Melanoma, Renal Cell Carcinoma, Urothelial Cancer, Gastric and Gastroesophageal Junction Cancer, Hepatocellular Carcinoma, Colorectal Cancer, Breast Cancer, Head and Neck Cancer, Other Cancers); By End User (Hospitals and Cancer Centers, Specialty and Ambulatory Treatment Facilities); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

PD-1 and PD-L1 Inhibitors Market: Checkpoint Blockade Becomes Oncology’s Revenue Backbone

The Global PD-1 and PD-L1 Inhibitors Market was valued at USD 62.80 billion in 2025 and is projected to reach USD 109.70 billion by 2032, expanding at a CAGR of 8... Read More

Published Date: JUL-2026 | No Of Pages:170 | $ 4485

Psoriasis & Psoriatic Arthritis Therapeutics Market By Therapy Type (Topical Therapies, Conventional Systemic Drugs, Targeted Oral Therapies, Biologics, Supportive Anti-Inflammatory Therapies), By Drug Class (TNF-Alpha Inhibitors, IL-17/IL-17 Receptor Inhibitors, IL-23/IL-12 & IL-23 Inhibitors, PDE4 Inhibitors, JAK/TYK2 Inhibitors, Corticosteroids, Other Therapies), By Indication (Plaque Psoriasis, Psoriatic Arthritis, Other Psoriasis Types), By Route of Administration (Topical, Oral, Injectable), By End User (Hospitals, Dermatology Clinics, Rheumatology Clinics, Specialty Clinics, Homecare Settings), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Psoriasis & Psoriatic Arthritis Therapeutics Market: Targeted Treatment, Long-Term Disease Control, and Access Shape Competition

The Global Psoriasis & Psoriatic Arthritis Therapeutics Market was valued at approximately USD 34.8 billion in 2025 and is projecte... Read More

Published Date: JUL-2026 | No Of Pages:162 | $ 4485

Mucopolysaccharidosis Treatment Market By Treatment Type (Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplantation, Supportive Care and Symptomatic Treatment, Emerging Gene and Cell Therapies), By Disease Type (MPS I, MPS II, MPS III, MPS IVA, MPS VI, MPS VII, Other MPS Types), By End User (Hospitals, Specialty Clinics, Research and Academic Institutions), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Microfluidic Drug Delivery Technologies Market: From Nanoparticle Formulation to Recurring Micro-Pump Revenue

The Global Microfluidic Drug Delivery Technologies Market was valued at USD 2.34 billion in Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

Molluscum Contagiosum Treatment Market By Treatment Type (FDA-Approved Prescription Therapies, Physical Removal Procedures, Off-Label Topical Therapies, Supportive and Immune-Directed Treatments), By Administration Setting (Healthcare Provider-Administered Treatment, Home-Based Treatment), By Patient Group (Pediatric Patients, Adults, Immunocompromised Patients), By Distribution Channel (Dermatology and Pediatric Clinics, Hospital Outpatient Departments, Retail Pharmacies, Mail-Order Pharmacies, Patient-Support Services), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Molluscum Contagiosum Treatment Market: Prescription Approvals Create a Defined Dermatology Market

The Global Molluscum Contagiosum Treatment Market was valued at approximately USD 0.72 million in 2025 and is projected to reach approximately USD 1.32 million by 2032, ... Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

Uveal Melanoma Treatment Market By Treatment Type (Radiation Therapy, Surgical Treatment, Systemic Drug Therapy, Liver-Directed Therapy); By Application (Localized Uveal Melanoma, Unresectable or Metastatic Uveal Melanoma); By End User (Hospitals and Cancer Centers, Ocular Oncology Centers, Radiation Oncology Centers, Specialty Clinics and Infusion Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Uveal Melanoma Treatment Market — Specialized Local Care and Recurring Metastatic Therapy Reshape Commercial Value

The Global Uveal Melanoma Treatment Market was valued at USD 0.95 billion in 2025 and is project... Read More

Published Date: JUL-2026 | No Of Pages:157 | $ 4485

Prader-Willi Syndrome Treatment Market By Product (VYKAT XR (Diazoxide Choline Extended-Release), Recombinant Human Growth Hormone, Hormone Replacement Therapies, Metabolic and Symptom-Directed Medicines, Investigational Therapies, Supportive Care Services); By Application (Hyperphagia Management, Growth Failure and Body-Composition Management, Hormone Deficiency Management, Metabolic Complication Management, Sleep and Behavioral Symptom Management, Developmental and Nutritional Support); By End User (Hospitals, Specialty Endocrinology Clinics, Genetics and Rare-Disease Clinics, Multidisciplinary PWS Centers, Specialty Pharmacies, Homecare Settings); By Distribution Channel (Specialty Pharmacies, Hospital Pharmacies, Retail and Community Pharmacies, Public Growth Hormone Programs); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Prader-Willi Syndrome Treatment Market — Commercial Evolution, Access Dynamics, and Competitive Outlook

The Global Prader-Willi Syndrome Treatment Market was valued at USD 680 million in 2025 and is projected to... Read More

Published Date: JUL-2026 | No Of Pages:179 | $ 4485

Adrenoleukodystrophy Market By Disease Type (Childhood Cerebral Adrenoleukodystrophy, Adrenomyeloneuropathy, Adrenal Insufficiency, Adult Cerebral Adrenoleukodystrophy, Other Forms), By Treatment (Hematopoietic Stem Cell Transplantation, Gene Therapy, Adrenal Hormone Replacement, Symptomatic and Supportive Care, Emerging Oral Therapies), By Diagnostic Service (Newborn Screening, VLCFA Testing, ABCD1 Genetic Testing, Brain MRI, Adrenal Function Testing, HLA and Donor Matching), By End User (Hospitals and Transplant Centers, Leukodystrophy and Neurology Clinics, Genetic Testing Laboratories, Endocrinology Clinics, Academic and Clinical Research Institutions), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Adrenoleukodystrophy Market: Newborn Screening, Early Treatment, and the AMN Pipeline Reshape Rare-Disease Care

The Global Adrenoleukodystrophy Market was valued at USD 80 million in 2025 and is projected to reach USD 650 million by 2032, expanding at a CAGR of 34.9% ... Read More

Published Date: JUL-2026 | No Of Pages:170 | $ 4485

NaV1.8 Inhibitors Market By Product (Suzetrigine/Journavx, LTG-001, LTG-305, STC-004, VX-993, Grünenthal NaV1.8 Inhibitor, Other Investigational NaV1.8 Inhibitors), By Application (Moderate-to-Severe Acute Pain, Postoperative Pain, Painful Diabetic Peripheral Neuropathy, Other Chronic Peripheral Neuropathic Pain), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Pain Clinics, Academic and Clinical Research Institutions), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

NaV1.8 Inhibitors Market: A New Non-Opioid Pain Treatment Class Enters Commercial Healthcare

The Global NaV1.8 Inhibitors Market was valued at USD 0.06 billion in 2025 and is projected to reach USD 2.35 billion by 2032, expanding at a CAGR of  68.4% during 2026&n... Read More

Published Date: JUL-2026 | No Of Pages:170 | $ 4485

Postmenopausal Vaginal Atrophy Market By Treatment (Vaginal Estrogen, Vaginal Moisturizers and Lubricants, Prasterone, Ospemifene, Systemic Hormone Therapy, Regenerative and Energy-Based Treatments), By Product Form (Creams, Tablets and Inserts, Vaginal Rings, Oral Tablets, Gels and Moisturizers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Clinics), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Postmenopausal Vaginal Atrophy Market: Untreated GSM Population Supports Long-Term Therapy Demand

The Global Postmenopausal Vaginal Atrophy Market was valued at USD 3.10 billion in 2025 and is projected to reach USD 5.35 billion by 2032, expanding at a CAGR of 8.3% du... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Netherton Syndrome Market By Product Type (Topical Supportive Care Products, Off-Label Systemic Therapies, Disease-Specific Topical Therapies, Disease-Specific Systemic Therapies, Anti-Infective Treatments); By Application (Skin Barrier Management, Inflammation Control, Infection Management, Severe and Systemic Disease Management); By End User (Hospitals, Dermatology Clinics, Pediatric Specialty Clinics, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Netherton Syndrome Market: Targeted Therapies Begin to Reshape a Supportive-Care Market

The Global Netherton Syndrome Market was valued at USD 28.88 million in 2025 and is projected to reach USD 65.42 million by 2032,... Read More

Published Date: JUL-2026 | No Of Pages:165 | $ 4485

DHODH Inhibitors Market (Dihydroorotate Dehydrogenase Inhibitors Market) By Product (Leflunomide, Teriflunomide, Vidofludimus Calcium, Brequinar, PTC299, Other Investigational DHODH Inhibitors), By Application (Rheumatoid Arthritis, Multiple Sclerosis, Oncology, Infectious Diseases, Other Autoimmune and Inflammatory Disorders), By End User (Hospitals, Specialty Clinics, Academic and Clinical Research Institutions), By Geography, Segment Revenue Estimation, Forecast: 2026–2032 

DHODH Inhibitors Market: Generic Autoimmune Demand and Late-Stage MS Innovation Reshape Commercial Value

The Global DHODH Inhibitors Market was valued at USD 1.20 billion in 2025 and is projected to reach USD 2.05 billion by 2032, expanding at a CAGR of 10.0% during 2... Read More

Published Date: JUL-2026 | No Of Pages:160 | $ 4485

Chronic Gout Market By Product Type (Urate-Lowering Therapies, Anti-Inflammatory Therapies, Combination and Supportive Therapies), Application (Long-Term Urate Reduction, Acute Gout Flare Management, Flare Prevention, Chronic Tophaceous Gout, Refractory and Uncontrolled Gout), End User (Hospitals, Rheumatology Clinics, Primary Care Clinics, Specialty Infusion Centers, Retail and Hospital Pharmacies, Homecare Settings), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Chronic Gout Market: Treat-to-Target Care Turns an Adherence Gap into a Commercial Battleground

The Global Chronic Gout Market was valued at USD 3.35 billion in 2025 and is projected to reach USD 5.53 billion by 2032, expanding at a CAGR of 7.6% during 2026–2032... Read More

Published Date: JUL-2026 | No Of Pages:170 | $ 4485

Tumor Induced Osteomalacia Market By Product Type (Burosumab (Crysvita), Oral Phosphate Supplements, Active Vitamin D Analogs, Investigational FGFR Inhibitors); By Application (Unlocalized Tumors, Unresectable Tumors, Recurrent or Persistent TIO, Metastatic TIO); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Research and Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Tumor-Induced Osteomalacia Market: Surgical Cure Limits Long-Term Drug Demand While Targeted Therapy Builds a Recurring Revenue Pool

The Global Tumor-Induced Osteomalacia Market was valued at USD 118.6 million in 2025 and is projected to reach USD 170.4 million by 203... Read More

Published Date: JUL-2026 | No Of Pages:156 | $ 4485

Hairy Cell Leukemia Treatment Market By Treatment Approach (Watchful Waiting, Purine Analogue Therapy, Monoclonal Antibody Therapy, BRAF Inhibitor Therapy, BRAF and MEK Combination Therapy, BTK Inhibitor Therapy, Supportive Care, Emerging Therapies); By Disease Type (Classic Hairy Cell Leukemia, Hairy Cell Leukemia Variant); By Line of Therapy (First-Line Treatment, Relapsed and Refractory Treatment); By End User (Hospitals, Specialty Hematology Clinics, Cancer Treatment Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hairy Cell Leukemia Treatment Market: Long Remissions and Chemo-Free Competition Reshape a Rare-Disease Category

The Global Hairy Cell Leukemia Treatment Market was valued at USD 165 million in 2025 and is projected to reach USD 255 million by 2032, expanding at a CAG... Read More

Published Date: JUL-2026 | No Of Pages:140 | $ 4485

Hepatocellular Carcinoma Therapeutics Market By Treatment Type (Immunotherapy, Targeted Therapy, Liver-Directed Therapy, Radiation Therapy, Surgery and Transplantation, Supportive Care); By Disease Stage (Early-Stage HCC, Intermediate-Stage HCC, Advanced-Stage HCC); By Line of Therapy (First-Line Therapy, Second-Line Therapy, Later-Line Therapy); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Hospitals, Specialty Cancer Centers, Transplant Centers, Ambulatory Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hepatocellular Carcinoma Therapeutics Market: Immunotherapy Competition Extends from Advanced Disease into Earlier Treatment

The Global Hepatocellular Carcinoma Therapeutics Market is projected to grow from USD 4.65 billion in 2025 to USD 8.35 billion by 2032, expandi... Read More

Published Date: JUL-2026 | No Of Pages:160 | $ 4485

Bioregenerative Aesthetic Injectable Treatment Market By Product Type (Poly-L-Lactic Acid Injectables, Calcium Hydroxylapatite Injectables, Polynucleotide Injectables, Polycaprolactone Injectables, Poly-D,L-Lactic Acid Injectables, Other Bioregenerative Injectables); By Application (Facial Volume Restoration, Fine Lines and Wrinkle Correction, Skin Firmness and Elasticity Improvement, Facial Contouring, Neck and Décolletage Rejuvenation, Body Contouring and Skin Quality Improvement); By End User (Dermatology Clinics, Plastic Surgery Clinics, Medical Spas, Aesthetic Medicine Clinics, Hospitals and Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Bioregenerative Aesthetic Injectable Treatment Market: Repeat Procedures and Body Applications Expand Biostimulator Revenue

The Global Bioregenerative Aesthetic Injectable Treatment Market was valued at USD 1.4 billion in 2025 and is projected to reach USD 3.0 billion... Read More

Published Date: JUL-2026 | No Of Pages:153 | $ 4485

Medical Foods Market By Route of Administration (Oral, Enteral); By Product Form (Powder, Liquid, Tablets & Capsules, Semi-Solid Formulations, Others); By Application (Cancer, Diabetic Neuropathy, Alzheimer’s Disease, ADHD, Depression, Chronic Kidney Disease, Gastrointestinal Disorders, Metabolic Disorders, Rare & Orphan Diseases, Others); By Age Group (Adult, Geriatric, Pediatric); By End User (Hospitals & Clinics, Home Healthcare, Specialty Clinics, Long-Term Care Facilities, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Direct Sales, Others); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Medical Foods Market Tracks Disease-Specific Nutrition Demand and Clinical Outcome Optimization

The Global Medical Foods Market was valued at USD 26.1 billion in 2025 and is projected to reach USD 39.8 billion by 2032... Read More

Published Date: JUN-2026 | No Of Pages:167 | $ 4485

Female Sexual Dysfunction Treatment Market By Disease Type (Hypoactive Sexual Desire Disorder (HSDD), Dyspareunia, Female Sexual Arousal Disorder, Orgasmic Disorder, Others); By Drug Type (Estrogen Therapy, Ospemifene, Flibanserin (Addyi), Bremelanotide (Vyleesi), Testosterone Therapy, Other Therapies); By Route of Administration (Oral, Topical, Injectable, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); By Patient Group (Premenopausal Women, Postmenopausal Women); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Female Sexual Dysfunction Treatment Market Tracks Rising Diagnosis Rates and Expanding Therapeutic Options

The Global Female Sexual Dysfunction Treatment Market was valued at USD 540 million in 2025 and is projected to reach Read More

Published Date: JUN-2026 | No Of Pages:159 | $ 4485

Hospital and Nursing Home Probiotics Market By Function (Gut Health, Immunity Support, General Wellness, Infection Prevention Support, Other Clinical Uses); By Product Type (Capsules, Powders, Liquid Formulations, Soft Chews, Probiotic Yogurt & Nutritional Formats); By Patient Group (Elderly Patients, Adults, Patients with GI Disorders, Immunocompromised Patients, Infants & Pediatric Patients); By Channel (Hospitals, Nursing Homes); By Probiotic Strain Type (Lactobacillus, Bifidobacterium, Saccharomyces boulardii, Multi-Strain Formulations, Other Strains); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hospital and Nursing Home Probiotics Market Tracks Preventive Care Economics and Infection Risk Reduction

The Global Hospital and Nursing Home Probiotics Market was valued at USD 1.69 billion in 2025 and is projected to reach ... Read More

Published Date: JUN-2026 | No Of Pages:161 | $ 4485

Dental Services Market By Service Type (Preventive Dentistry, Restorative Dentistry, Orthodontics, Cosmetic Dentistry, Endodontics, Periodontics, Prosthodontics, Oral Surgery); By Procedure Category (General Dentistry, Implant Dentistry, Orthodontics & Aligners, Cosmetic Procedures, Surgical Procedures); By Patient Group (Adults, Geriatric Patients, Pediatric Patients); By Provider Type (Independent Dental Clinics, Group Dental Practices, Dental Service Organizations (DSOs), Hospital-Based Dentistry, Academic & Institutional Dentistry); By Technology Adoption (Conventional Dentistry, Digital Imaging Dentistry, CAD/CAM Dentistry, Clear Aligner-Based Dentistry, AI-Assisted Diagnostics); By Payment Model (Private Insurance, Out-of-Pocket Spending, Public Insurance Programs, Employer-Sponsored Dental Plans); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Dental Services Market Benefits from Preventive Care Expansion and High-Value Specialty Procedure Adoption

The Global Dental Services Market was valued at USD 489.3 billion in 2025 and is projected to reach USD 789.3 billion b... Read More

Published Date: JUN-2026 | No Of Pages:160 | $ 4485

H3 Inverse Agonist Therapeutics Market By Indication (Narcolepsy With Excessive Daytime Sleepiness, Narcolepsy With Cataplexy, Pediatric Narcolepsy, Idiopathic Hypersomnia, Prader-Willi Syndrome Related Sleepiness); By Product Type (Approved Commercial H3 Inverse Agonists, Pipeline H3 Therapeutics); By Age Group (Adult Patients, Pediatric And Adolescent Patients); By Revenue Type (Core Approved Market Revenue, Lifecycle Expansion Revenue, Pipeline Opportunity Revenue); By Geography, Segment Revenue Estimation, Forecast, 2025–2035

Introduction And Strategic Context

The Global H3 Inverse Agonist Therapeutics Market is entering a more commercially defined phase as histamine-based wakefulness therapies gain stronger positioning across specialty neurology and sleep disorder treatme... Read More

Published Date: MAY-2026 | No Of Pages:163 | $ 4485

Radiosensitizer Market By Drug Type (Chemotherapy-Based Radiosensitizers, Hypoxia-Targeted Radiosensitizers, Nanoparticle and Targeted Radiosensitizers, Immunotherapy-Linked Radiosensitizers); By Mechanism of Action (DNA Damage Enhancement, Hypoxia Modification, Cell Cycle Regulation, Immune Microenvironment Modulation); By Cancer Type (Head and Neck Cancer, Glioblastoma and Brain Tumors, Cervical Cancer, Lung Cancer, Gastrointestinal and Rectal Cancers); By End User (Cancer Hospitals and Oncology Centers, General Hospitals, Academic and Research Institutes, Ambulatory Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Introduction And Strategic Context

The Global Radiosensitizer Market is projected to expand at a CAGR of 6.8%, increasing from USD 2.4 billion in 2025 to USD 3.8 billion by 2032, acco... Read More

Published Date: MAY-2026 | No Of Pages:160 | $ 4485

TLR Agonists Market By Type (TLR7 Agonists, TLR8 Agonists, TLR9 Agonists, Other TLR Agonists [TLR2, TLR3, TLR4, etc.]); By Application (Oncology, Infectious Diseases, Vaccine Adjuvants, Dermatology, Others [Autoimmune & Rare Diseases]); By Route of Administration (Injectable, Topical, Oral, Intranasal, Others); By End User (Hospitals & Specialty Clinics, Research & Academic Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations [CROs]); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TLR Agonists Market is projected to grow at a CAGR of 8.9% , valued at USD 1.2 billion in 2024 , and expected to reach a... Read More

Published Date: APR-2026 | No Of Pages:174 | $ 4485

Ophthalmic Topical Therapeutics Market By Drug Class (Anti-glaucoma Drugs, Dry Eye Medications, Anti-inflammatory Drugs, Anti-infective Agents, Anti-allergy Drugs); By Dosage Form (Eye Drops, Ointments, Gels, Suspensions & Emulsions, Preservative-free Units); By Indication (Glaucoma, Dry Eye Syndrome, Ocular Infections, Post-surgical Care, Allergic Conjunctivitis); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Ophthalmic Topical Therapeutics Market is projected to grow at a CAGR of 6.8% , valued at USD 16.2 billion in 2024 , and... Read More

Published Date: MAR-2026 | No Of Pages:154 | $ 4485

Grand Mal Seizure Market By Treatment Type (AEDs, Neuromodulation Devices, Surgical Interventions); By Drug Generation (First-Generation, Second-Generation, Third-Generation AEDs); By Route of Administration (Oral, Injectable, Nasal/Buccal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By End User (Hospitals, Neurology Clinics, Homecare/Patient-Centric); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Grand Mal Seizure Market will witness a steady CAGR of 6.8% , valued at USD 2.9 billion in 2024 , expec... Read More

Published Date: MAR-2026 | No Of Pages:175 | $ 4485

Kidney Transplantation Therapeutics Market By Therapeutic Class (Induction Therapy, Maintenance Immunosuppressants, Anti-Rejection Treatments); By Drug Type (Calcineurin Inhibitors, Antimetabolites, mTOR Inhibitors, Biologic Immunosuppressants); By End User (Hospitals and Transplant Centers, Specialty Clinics, Ambulatory Care Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Kidney Transplantation Therapeutics Market is projected to expand at a CAGR of 8.6% , reaching USD 6.9 billion by 2030 , up from an USD 4.1 billio... Read More

Published Date: MAR-2026 | No Of Pages:153 | $ 4485

Neurocutaneous Disorder Market By Disorder Type (Neurofibromatosis, Tuberous Sclerosis Complex, Sturge Weber Syndrome, Von Hippel Lindau Disease, Others); By Treatment Type (Pharmacological Treatment, Surgical Treatment, Laser and Dermatological Treatment, Supportive Therapies); By End User (Hospitals, Specialty Clinics, Research and Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neurocutaneous Disorder Market will witness a steady expansion at a CAGR of 6.8% , valued at US... Read More

Published Date: MAR-2026 | No Of Pages:186 | $ 4485

Bone Marrow Transplantation for Rare Blood Disorders Market By Transplant Type (Allogeneic Transplantation, Autologous Transplantation); By Disorder Type (Thalassemia, Sickle Cell Disease, Aplastic Anemia, Inherited Immunodeficiency Disorders); By Donor Source (Matched Related Donor, Matched Unrelated Donor, Haploidentical Donor, Cord Blood Stem Cells); By End User (Specialized Transplant Centers, Academic and Research Hospitals, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bone Marrow Transplantation for Rare Blood Disorders Market is projected to grow at a CAGR of 8.4% , valued at USD 6.7 billion in 2024 , and expected to r... Read More

Published Date: MAR-2026 | No Of Pages:163 | $ 4485

Lysosomal Storage Disorders Market By Therapy Type (Enzyme Replacement Therapy, Substrate Reduction Therapy, Pharmacological Chaperone Therapy, Gene Therapy); By Disease Indication (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidoses, Other Lysosomal Storage Disorders); By Route of Administration (Intravenous, Oral, Intrathecal); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lysosomal Storage Disorders Market is projected to grow at a CAGR of 8.6% , rising from an USD 9.1 billion in 2024 to USD 14.9 billion by 2030 , according... Read More

Published Date: MAR-2026 | No Of Pages:161 | $ 4485

Fanconi Anemia Gene Therapy Market By Therapy Approach (Ex Vivo Gene Therapy, In Vivo Gene Therapy); By Vector Technology (Lentiviral Vectors, Adeno Associated Viral Vectors, Gene Editing Platforms); By End User (Hospitals with Bone Marrow Transplant Units, Specialized Genetic Treatment Centers, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fanconi Anemia Gene Therapy Market is projected to witness a robust CAGR of 18.6% between 2024 and 2030 , valued at USD 95.0 mill... Read More

Published Date: MAR-2026 | No Of Pages:176 | $ 4485

GIPR Antagonist Market By Drug Class and Target Type (Dual GLP-1 plus GIPR Modulators, Selective Oral GIPR Antagonists, Adjunct Biologics); By Mechanism of Action (Incretin Synergy, Insulin Pathway Modulation, Maintenance and Durability Mechanisms, Weight-Loss-Independent Metabolic Effects); By Indication (Obesity, Type 2 Diabetes with Obesity, Metabolic Syndrome, NASH and Other Metabolic Disorders); By Route of Administration (Injectable Peptides, Oral Small Molecules, Injectable Antibodies); By Patient Profile; By Geography, Segment Revenue Estimation and Forecast, 2027–2035.

Introduction and Strategic Context

The Global GIPR Antagonist Market will emerge as a high-growth metabolic therapeutics segment, beginning commercial inflection around 2027, reaching approximately USD 3.0 Billion by 2030Read More

Published Date: FEB-2026 | No Of Pages:153 | $ 4485

Oncology G Protein Coupled Receptors (GPCR) Market By Therapeutic Class (Small Molecule Modulators, Monoclonal Antibodies, Peptide Agonists Antagonists, Others); By Target Type (Chemokine Receptors, Protease Activated Receptors, Lysophosphatidic Acid Receptors, Other Class A B C GPCRs); By Mechanism of Action (Agonists, Antagonists, Inverse Agonists, Allosteric Modulators); By End User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Oncology G Protein-Coupled Receptors (GPCR) Market will witness a robust CAGR of 5.0 % , valued at $4.0 billion in 2024 ... Read More

Published Date: FEB-2026 | No Of Pages:164 | $ 4485

Polynucleotides Injectable Market By Product Type (Dermal Fillers, Joint Injectables, Regenerative Gels); By Application (Aesthetic Dermatology, Orthopedic Therapy, Wound Healing); By End User (Dermatology Clinics, Hospitals, Aesthetic Chains, ASCs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Polynucleotides Injectable Market is witnessing robust growth, driven by rising demand for regenerative aesthetic treatments, advancements in nucleic acid science, and increasing adoption ... Read More

Published Date: FEB-2026 | No Of Pages:191 | $ 4485

Topical Wound Agents Market by Product Type (Antibiotics, Antiseptics, Enzymatic Agents, Moisture-Retentive Products, Growth Factors, Hemostatic Agents); by Wound Type (Chronic Wounds, Acute Wounds); by End User (Hospitals, ASCs, Clinics, Home Healthcare); by Geography – Segment Revenue Estimation and Forecast, 2024 to 2030.

Introduction And Strategic Context

The Global Topical Wound Agents Market is projected to expand at a CAGR of 7.74%, valued at approximately USD 1.78 billion in 2024, and is expected to reach around USD 2.84 b... Read More

Published Date: FEB-2026 | No Of Pages:169 | $ 4485

Image Guided Therapy Market By Product Type (Imaging Systems, Navigation Software, Instruments & Accessories); By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology & Urology); By End User (Hospitals & Academic Centers, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Image Guided Therapy Market is witnessing rapid transformation as modern medicine advances toward precision, personalization, and minimally invasive intervention. Image guided therapy (IGT... Read More

Published Date: FEB-2026 | No Of Pages:195 | $ 4485

RNA Targeted Small Molecules Market By Target RNA Type (mRNA, pre-mRNA and Splice Variants, Non-coding RNA, Repeat Expansion RNA); By Application (Genetic Disorders, Oncology, Neurodegenerative Diseases, Infectious Diseases, Others); By End User (Pharmaceutical and Biotechnology Companies, Academic & Research Institutes, CROs, Hospitals & Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global RNA Targeted Small Molecules Market is at the forefront of next-generation therapeutics, representing a paradigm shift in drug discovery by expanding the “ druggable ” genome b... Read More

Published Date: FEB-2026 | No Of Pages:163 | $ 4485

Rare Hemophilia Factors Market By Product Type (Plasma-Derived Coagulation Factors, Recombinant Coagulation Factors); By Indication (Factor VII Deficiency, Factor XI Deficiency, Factor XIII Deficiency, Factor V Deficiency, Factor X Deficiency, Fibrinogen Deficiency, Others); By End User (Hospitals & Hemophilia Treatment Centers, Specialty Pharmacies, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Rare Hemophilia Factors Market addresses one of the most specialized and underserved areas within hematology — the treatment of rare bleeding disorders caused by deficiencies in coag... Read More

Published Date: FEB-2026 | No Of Pages:191 | $ 4485

Diabetic Foot Ulcer Biologics Market By Product Type (Growth Factors, Skin Substitutes, Extracellular Matrix-Based Products, Amniotic Membranes); By Application (Neuropathic Ulcers, Ischemic and Neuro-Ischemic Ulcers, Infected or Chronic Non-Healing Ulcers); By End User (Hospitals & Wound Care Centers, Ambulatory Surgical Centers, Homecare Settings, Podiatry & Vascular Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diabetic Foot Ulcer (DFU) Biologics Market is emerging as a critical frontier in chronic wound care, driven by the escalating global burden of diabetes and the clinical challenges posed by... Read More

Published Date: FEB-2026 | No Of Pages:188 | $ 4485

Neurofibromatosis Type 1 Market By Drug Class (MEK Inhibitors, Pain Management Drugs, Anticonvulsants); By Route of Administration (Oral, Injectable); By End User (Tertiary Hospitals, Pediatric Specialty Hospitals, Genetic Counseling Centers, Clinical Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neurofibromatosis Type 1 Market is positioned for steady expansion between 2024 and 2030 , driven by rising diagnosis rates, growing patient registries, and emerging gene-... Read More

Published Date: FEB-2026 | No Of Pages:198 | $ 4485

Lymphedema Treatment Market By Treatment Type (Compression Therapy, Surgical Treatment, Drug Therapy, Physiotherapy); By Disease Type (Primary Lymphedema, Secondary Lymphedema); By End User (Hospitals, Specialty Clinics, Home Healthcare, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lymphedema Treatment Market is poised to grow at a CAGR Of 6.8%, reaching an estimated value of USD 2.1 Billion In 2030, up from USD 1.4 Billion In 2024, ... Read More

Published Date: FEB-2026 | No Of Pages:176 | $ 4485

U.S. Post-Menopausal Dyspareunia Market By Therapy Type (Local Vaginal Estrogen, Non-Estrogen Prescription, GSM-Specific OTC); By Route of Administration (Vaginal, Oral); By Patient Type (Estrogen-Eligible, Estrogen-Averse / Contraindicated); By Care Setting (OB-GYN, Primary Care, Retail / OTC); By Region (North America); Segment Revenue Estimation, Forecast, 2025–2035

1. Introduction and Strategic Context

The U.S. Post-Menopausal Dyspareunia Market — anchored within the broader Genitourinary Syndrome of Menopause (GSM) space — is projected to grow from USD 180 million in 2025 to approxima... Read More

Published Date: DEC 2025 | No Of Pages:179 | $ 4485

Microbiome-Based Therapies For Vaginal & Reproductive Health Market By Indication (Recurrent Bacterial Vaginosis, Pregnancy-Associated Dysbiosis, Infertility-Linked Dysbiosis, Postmenopausal Vaginal Dysbiosis); By Therapeutic Modality (Live Biotherapeutic Products [Single-Strain, Multi-Strain], Vaginal Microbiota Transplants, Other Experimental Modalities); By Route of Administration (Vaginal, Oral, Hybrid); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The Global Microbiome-Based Therapies For Vaginal & Reproductive Health Market is forecast to expand steadily at a CAGR of 6.8%, reaching approximately USD 1.04 billion in 2030, ... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Chronotherapy Market By Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Sleep & Neurological Disorders); By Drug Delivery System (Oral Formulations, Transdermal Systems, Injectables, Smart Drug Delivery Devices); By End User (Hospitals & Specialty Clinics, Outpatient Clinics, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronotherapy Market growing at 8.1% CAGR, expanding from USD 4.2 billion in 2024 to USD 6.7 billion by 2030, supported by circadian rhythm therap... Read More

Published Date: JAN-2026 | No Of Pages:155 | $ 4485

Parasomnia Treatment Market By Treatment Type (Pharmacological, Non-Pharmacological); By Patient Demographics (Adult, Pediatric); By End User (Hospitals, Specialty Sleep Clinics, Homecare Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Parasomnia Treatment Market growing at 9.5% CAGR, expanding from USD 1.2 billion in 2024 to USD 2.1 billion by 2030, fueled by sleep disorder ther... Read More

Published Date: JAN-2026 | No Of Pages:172 | $ 4485

Chronic Lower Back Pain Treatment Market By Product Type (Pharmacological Therapy, Device-Based Therapy, Regenerative Therapy, Digital Therapeutics); By Treatment Modality (Minimally Invasive Procedures, Neuromodulation, Rehabilitation Programs, Combination Therapy); By End User (Hospitals, Specialty Pain Clinics, Ambulatory Surgical Centers, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Lower Back Pain Treatment Market growing at 6.5% CAGR, expanding from USD 12.7 billion in 2024 to USD 18.5 billion by 2030, driven by pain... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Hypersomnia Treatment Market By Product Type (Oxybates, Wake-Promoting Agents, Central Nervous System Stimulants, Histamine H3 Receptor Antagonists/Inverse Agonists, Orexin Receptor Agonists, Other Pharmacological Treatments); By Application (Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia, Other Hypersomnia Disorders); By End User (Hospitals, Sleep Clinics and Sleep Centers, Neurology Clinics, Specialty Clinics, Homecare Settings); By Distribution Channel (Specialty Pharmacies, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Hypersomnia Treatment Market: Diagnosis Delays, Franchise Expansion, and Orexin Competition Reshape Revenue

The Global Hypersomnia Treatment Market was valued at USD 3.42 billion in 2025 and is projected to reach USD 5.41 billion by 2032, growing at a CAGR of 6.8%, ac... Read More

Published Date: JUL-2026 | No Of Pages:189 | $ 4485

Marfan Syndrome Management Market By Product (Pharmaceutical Products, Diagnostic and Monitoring Products, Surgical Products and Implants, Supportive Care Products); By Application (Cardiovascular Management, Ophthalmic Management, Orthopedic and Skeletal Management, Pulmonary Management); By End User (Hospitals and Specialty Clinics, Diagnostic Laboratories, Ambulatory Surgical Centers, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Marfan Syndrome Management Market: Lifelong Surveillance, Preventive Aortic Care and Emerging Disease-Targeted Therapies

The Global Marfan Syndrome Management Market was valued at USD 746.3 million in 2025 and is projected to reach USD 1.19 billion by 2032, expanding ... Read More

Published Date: JUL-2026 | No Of Pages:161 | $ 4485

Pediatric Oncology Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Supportive Care & Others); By Route of Administration (Intravenous, Oral, Other Routes); By End User (Specialized Pediatric Oncology Centers, General Hospitals, Outpatient Clinics & Ambulatory Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pediatric Oncology Therapeutics Market is expected to witness a robust CAGR of 9.1%, valued at USD 4.8 billion in 2024, and anticipated t... Read More

Published Date: JAN-2026 | No Of Pages:179 | $ 4485

Neurogenic Bladder Infections Market By Product Type (Pharmacological Therapies, Medical Devices, Diagnostics); By Treatment Modality (Oral Therapies, Intravesical Therapy, Catheter-Based Interventions); By End User (Hospitals, Rehabilitation Centers, Outpatient Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Neurogenic Bladder Infections Market: Recurrent UTI Burden Shifts Value Toward Reimbursed Catheter Systems and Specialist Prevention

 

The Global Neurogenic Bladder Infections Market is estimated to reach USD 4.05 billion in 202... Read More

Published Date: JUL-2026 | No Of Pages:156 | $ 4485

Opioid Receptor Agonist Market By Product Type (Full Agonists, Partial Agonists, Mixed Agonist-Antagonists); By Receptor Type (Mu, Kappa, Delta); By Route of Administration (Oral, Injectable, Transdermal, Nasal, Sublingual); By End User (Hospitals, Retail Pharmacies, Rehabilitation Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Opioid Receptor Agonist Market is poised for moderate expansion, reaching an estimated USD 21.6 billion in 2024, with projections hitting USD 29.1 billion by 2030, reflect... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Cyclic Heavy Menstrual Bleeding (CHMB) Market By Treatment Type (Pharmacological Therapies, Surgical and Device-Based Therapies); By Cause (Uterine Fibroids, Hormonal Imbalance, Coagulopathy); By End User (Hospitals, Gynecology Clinics, Ambulatory Surgical Centers, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclic Heavy Menstrual Bleeding (CHMB) Market is expected to expand steadily from 2024 to 2030, driven ... Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485

Cycloplegic Agents Market By Drug Type (Atropine-based Agents, Cyclopentolate-based Agents, Tropicamide-based Agents); By Application (Diagnostic Refraction, Myopia Management, Uveitis and Inflammatory Conditions, Pre/Post-Operative Use); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cycloplegic Agents Market will witness a steady CAGR of 5.8%, valued at around USD 540.0 million in 2024, and is expected to cross Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Multidrug-Resistant Bacteria Market By Drug Class (Beta-lactam Combinations, Oxazolidinones & Glycopeptides, Tetracyclines & Derivatives, Polymyxins, Others [Phage Therapy, CRISPR-based Antimicrobials, Novel Peptides]); By Pathogen Type (Gram-Negative Bacteria, Gram-Positive Bacteria, Anaerobic and Atypical Pathogens); By Application Setting (Hospital-Acquired Infections, Community-Acquired Infections, Long-Term Care & Post-Acute Care, Military, Emergency, and Trauma Care); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Multidrug-Resistant Bacteria Market: AMR Mortality, Gram-Negative Resistance, and New Antibiotic Approvals Rebuild the Value of Anti-Infective Innovation

The Global Multidrug-Resistant Bacteria Market was valued at USD 13.5 billion in 2025 and is projected to reach US... Read More

Published Date: JUN-2026 | No Of Pages:154 | $ 4485

Gastric Ulcer Treatment Market By Treatment Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blockers, H2-Receptor Antagonists, Antibiotic Combination Therapies, Bismuth-Based Therapies, Mucosal Protective Agents, Antacids, Endoscopic Treatment, Surgical Treatment); By Application (Helicobacter pylori-Associated Gastric Ulcers, NSAID-Induced Gastric Ulcers, Bleeding Gastric Ulcers, Refractory Gastric Ulcers, Recurrent Gastric Ulcers, Perforated Gastric Ulcers, Stress-Related Gastric Ulcers); By End User (Hospitals, Gastroenterology Clinics, Ambulatory Endoscopy Centers, Primary Care Clinics, Retail Pharmacies, Hospital and Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Gastric Ulcer Treatment Market: Resistance-Aware H. pylori Therapy, Follow-Up Care, and Payer Access Redirect Revenue

The Global Gastric Ulcer Treatment Market was valued at USD 5.63 billion in 2025 and is projected to reach USD 8.57 billion by 2032, growing at a CAGR... Read More

Published Date: JUL-2026 | No Of Pages:195 | $ 4485

Tularemia Therapeutics Market By Product Type (Antibiotics, Novel Therapeutics); By Route of Administration (Oral, Intravenous, Intramuscular); By End User (Hospitals, Public Health Agencies, Military/Biodefense, Research Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Tularemia Therapeutics Market: Updated Treatment Guidance, Outbreak Volatility, and Biodefence Preparedness Reshape Commercial Value

The Global Tularemia Therapeutics Market is estimated at USD 155.0 million in 2025 and is projected t... Read More

Published Date: JUL-2026 | No Of Pages:167 | $ 4485

Galectin Inhibitor Therapeutics Market By Type (Small Molecule Inhibitors, Monoclonal Antibodies, Glycomimetics); By Indication (Oncology, Fibrosis, Inflammatory and Autoimmune Disorders); By Route of Administration (Oral, Intravenous); By End User (Specialty Cancer Centers, Hepatology Clinics, Academic Research Hospitals, Community Oncology Networks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Galectin Inhibitors Market Advances Across Fibrosis, Oncology & Immune-Mediated Disease Pipelines (Last Updated on: June-2026)

The Global Galectin Inhibitor Therapeutics Market will witness a robust CAGR of 24.8%, valued at USD 0.67 b... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Lymphangioleiomyomatosis Market By Type (Sporadic LAM, TSC-Associated LAM); By Treatment (Sirolimus, Everolimus, Supportive Therapy, Lung Transplantation); By Diagnostic Modality (HRCT Imaging, VEGF-D Testing, Genetic Testing); By End User (Tertiary Hospitals, Pulmonology Clinics, Diagnostic Labs, Community Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lymphangioleiomyomatosis Market valued at USD 428 million in 2024 and projected to reach USD 610 million by 2030 at 6.1% CAGR, driven by rare dise... Read More

Published Date: JAN-2026 | No Of Pages:162 | $ 4485

Autoimmune Hepatitis Market By Disease Type (Type 1 Autoimmune Hepatitis, Type 2 Autoimmune Hepatitis, Seronegative Autoimmune Hepatitis); By Treatment Type (Corticosteroids, Conventional Immunosuppressants, Biologics & Targeted Therapies, Liver Transplant Interventions); By Diagnosis & Monitoring Method (Autoantibody Testing, IgG Quantification, Liver Function Testing, Liver Biopsy, Fibrosis Assessment Tools); By End User (Tertiary Care Hospitals, Specialty Clinics, Diagnostic Laboratories, Transplant Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Autoimmune Hepatitis Market: Lifelong Immunosuppression and Steroid-Sparing Innovation Expand a Focused Rare-Disease Opportunity

The Global Autoimmune Hepatitis Market is estimated at USD 183.99 million in 2025 and is projected to reach USD 228.13 million by 2032, exp... Read More

Published Date: JUL-2026 | No Of Pages:197 | $ 4485

Submental Fat Treatment Market By Treatment Modality (Injectables, Cryolipolysis, Laser, Radiofrequency, Surgical Liposuction); By End User (Dermatology Clinics, Plastic Surgery Centers, Medspas, Specialized Aesthetic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Submental Fat Treatment Market is projected to witness a robust CAGR of 12.1%, valued at USD 1.1 billion in 2024 and expected to reach USD 2.1 billion by 2030,Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Pleural Effusion Market By Type (Transudative Effusion, Exudative Effusion); By Treatment (Thoracentesis, Indwelling Pleural Catheter, Pleurodesis, Pharmacologic Management); By End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers, Home Healthcare, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pleural Effusion Market is projected to reach USD 1.82 billion by 2030 , rising from an estimated USD 1.25 billion in 2024 , expanding at a CAGR o... Read More

Published Date: JAN-2026 | No Of Pages:181 | $ 4485

Pericarditis Treatment Market By Treatment Type (Nonsteroidal Anti-Inflammatory Drugs, Colchicine, Corticosteroids, IL-1 Inhibitors, Immunosuppressive Therapies, Intravenous Immunoglobulin, Other Supportive Therapies); By Application (Acute Pericarditis, Recurrent Pericarditis, Chronic Pericarditis, Constrictive Pericarditis, Post-Pericardiotomy Syndrome); By End User (Hospitals, Specialty Cardiology Centers, Ambulatory Care Centers, Specialty Clinics, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Pericarditis Treatment Market: Recurrent Disease Shifts Revenue Toward Long-Duration Specialty Care

The Global Pericarditis Treatment Market was valued at USD 3.30 billion in 2025 and is projected to reach USD 5.41 billion by 2032, growing at a CAGR of 6.4%, according... Read More

Published Date: JUL-2026 | No Of Pages:191 | $ 4485

Onchocerciasis Treatment Market By Drug Class (Macrocyclic Lactones, Antibiotics, Anti-Wolbachia Agents); By Treatment Strategy (Mass Drug Administration, Selective/Targeted Treatment); By Distribution Model (Donation-Based, Government Procurement, NGO-Driven); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Onchocerciasis Treatment Market is poised to grow at a CAGR of 5.6% , rising from an estimated USD 297.5 million in 2024 to approximately... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Nasal Polyposis Treatment Market By Treatment Type (Intranasal Corticosteroids, Oral Corticosteroids, Biologics, Endoscopic Sinus Surgery, Supportive Therapies); By Disease Severity (Mild to Moderate CRSwNP, Severe Uncontrolled CRSwNP); By Biologic Class (IL-4/IL-13 Inhibitors, Anti-IgE Therapy, IL-5 Inhibitors, TSLP Inhibitors, Other Pipeline Biologics); By End User (Hospitals, ENT Specialty Clinics, Allergy & Pulmonology Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Nasal Polyposis Treatment Market Benefits from Severe CRSwNP Biologic Expansion and Steroid-Sparing Treatment Demand

The Global Nasal Polyposis Treatment Market was valued at USD 4.94 billion in 2025 and is projected to reach USD 7.79 billion by 2032, growing at a CAG... Read More

Published Date: JUL-2026 | No Of Pages:198 | $ 4485

Radiation Proctitis Market By Treatment Type (Medications, Endoscopic Therapies, Surgical Interventions); By Route of Administration (Oral, Rectal, Intravenous); By End User (Hospitals & Specialty Oncology Centers, Outpatient Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radiation Proctitis Market will witness a steady CAGR of 5.9%, valued at $494 million in 2024, expected to reach $701 million by 2030, confirms St... Read More

Published Date: JAN-2026 | No Of Pages:175 | $ 4485

Intracranial Aneurysm Market By Type (Ruptured Aneurysm, Unruptured Aneurysm); By Treatment (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others); By End User (Hospitals and Neurosurgery Centers, General Hospitals, ASCs, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Intracranial Aneurysm Market valued at USD 2.4 billion in 2024 and projected to reach USD 3.8 billion by 2030 at 8.1% CAGR, driven by neurovascula... Read More

Published Date: JAN-2026 | No Of Pages:164 | $ 4485

Hyperthyroidism Market By Treatment Type (Antithyroid Drugs, Radioactive Iodine Therapy, Surgery, Beta-Blockers); By Route of Administration (Oral, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hyperthyroidism Market is projected to grow at a CAGR of 7.3% , climbing from an estimated USD 1.9 billion in 2024 to nearly USD 2.9 billion by 20... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

Hypereosinophilic Syndrome Market By Drug Class (Corticosteroids, IL-5 Inhibitors, Tyrosine Kinase Inhibitors, Others); By Route of Administration (Oral, Subcutaneous, Intravenous); By End User (Specialty Clinics, Hospitals, Academic Medical Centers); By Geography, Segment Revenue Estimation, Forecast, 2025–2030

Introduction And Strategic Context

The Global Hypereosinophilic Syndrome Market is projected to grow at a steady CAGR of 6.3%, reaching an estimated valuation of USD 1.7 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:199 | $ 4485

Dental Fluoride Treatment Market By Product Type (Fluoride Varnishes, Fluoride Gels, Fluoride Foams, Prescription-Strength Toothpaste, Prescription-Strength Gels, Prescription-Strength Mouthrinses); By Delivery Format (Unit-Dose Cups, Single-Patient Blister Packs, Multidose Tubes, Applicator-Based Formats, Tray-Based Applications); By Patient Group (Children, Adolescents, Adults, Older Adults, High-Caries-Risk Patients); By End User (Dental Practices, Pediatric Dental Clinics, Primary-Care Settings, Community Oral-Health Programs, School-Based Dental Programs, Hospitals and Public Dental Services); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Dental Fluoride Treatment Market: Repeat Preventive Applications Create Recurring Consumable Demand

The Global Dental Fluoride Treatment Market was valued at USD 12.95 billion in 2025 and is projected to reach USD 19.65 billion by 2032, growing at a CAGR of 6.14%, acc... Read More

Published Date: JUL-2026 | No Of Pages:164 | $ 4485

Ear Infection Treatment Market By Product Type (Antibiotics, Antifungals, Analgesic and Anaesthetic Ear Drops, Antibiotic–Corticosteroid Combinations, Other Supportive Treatments); By Application (Acute Otitis Media, Recurrent Otitis Media, Acute Otitis Externa, Chronic Suppurative Otitis Media, Fungal Otitis Externa); By End User (Hospitals, ENT Clinics, Pediatric and Primary Care Clinics, Community and Retail Pharmacies, Other Healthcare Settings); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Ear Infection Treatment Market: Pharmacy Access, Stewardship, and Specialty Otic Products Reshape Commercial Value

The Global Ear Infection Treatment Market was valued at USD 13.63 billion in 2025 and is projected to reach USD 21.18 billion by 2032, growing at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:197 | $ 4485

Necrobiosis Lipoidica Market By Treatment Type (Topical Corticosteroids, Systemic Immunosuppressants, Biologics, Others); By Route of Administration (Topical, Oral, Injectable); By End User (Dermatology Clinics, Hospitals, Wound Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Necrobiosis Lipoidica Market is projected to grow at an estimated CAGR of 5.8%, valued at USD 178.6 million in 2024, and... Read More

Published Date: JAN-2026 | No Of Pages:156 | $ 4485

Disseminated Intravascular Coagulation Market By Product Type (Therapeutics, Diagnostic Assays, Supportive Care Solutions); By Application (Sepsis, Trauma, Oncology, Obstetric Complications); By End User (Hospitals, Specialized Diagnostic Laboratories, Critical Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Disseminated Intravascular Coagulation ( DIC ) Market is projected to witness a robust CAGR of 6.8%, valued at U... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Hemophagocytic Lymphohistiocytosis (HLH) Market By Treatment Type (Immunosuppressive Therapy, Targeted Biologics, Stem Cell Transplantation, Supportive Care); By Disease Form (Primary HLH, Secondary HLH); By End User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Hemophagocytic Lymphohistiocytosis (HLH) Market valued at USD 0.68 billion in 2024 and reaching USD 1.1 billion by 2030 at 8.1% CAGR, driven by ra... Read More

Published Date: JAN-2026 | No Of Pages:174 | $ 4485

Frozen Shoulder Treatment Market By Treatment Type (Physical Therapy and Rehabilitation, Corticosteroid Injections, Hydrodilatation, Pain Management Medications, Suprascapular Nerve Blocks, Manipulation Under Anesthesia, Arthroscopic Capsular Release, Transarterial Embolization); By Application (Primary Frozen Shoulder, Diabetes-Associated Frozen Shoulder, Post-Surgical Frozen Shoulder, Post-Traumatic Frozen Shoulder, Refractory Frozen Shoulder); By End User (Hospitals, Orthopedic Clinics, Physiotherapy and Rehabilitation Centers, Sports Medicine Clinics, Diagnostic and Interventional Radiology Centers, Ambulatory Surgical Centers, Pain Management Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Frozen Shoulder Treatment Market: Injection-Led Care and Hydrodilatation Keep Surgery Selective

The Global Frozen Shoulder Treatment Market was valued at USD 1.28 billion in 2025 and is projected to reach USD 1.99 billion by 2032, growing at a... Read More

Published Date: JUL-2026 | No Of Pages:200 | $ 4485

Estrogen Receptor Modulators Market By Drug Class (Selective Estrogen Receptor Modulators, Selective Estrogen Receptor Degraders, Estrogen Receptor Antagonists, Targeted Protein Degraders); By Product (Tamoxifen, Raloxifene, Clomiphene, Toremifene, Fulvestrant, Elacestrant, Imlunestrant, Vepdegestrant, Camizestrant, Other Estrogen Receptor Modulators); By Route of Administration (Oral, Injectable); By Application (Breast Cancer Treatment, Osteoporosis Management, Breast Cancer Risk Reduction, Fertility and Ovulation Induction, Gynecological and Menopausal Applications); By End User (Hospitals, Specialty Oncology Clinics, Fertility Clinics, Retail Pharmacies, Specialty Pharmacies, Academic and Clinical Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Estrogen Receptor Modulators Market: Precision Endocrine Therapies Reshaping Breast Cancer, Bone Health, and Reproductive Medicine

The Global Estrogen Receptor Modulators Market was valued at an estimated USD 4.72 billion in 2025 and is projected to reach USD 9.08 bil... Read More

Published Date: AUG-2026 | No Of Pages:175 | $ 4485

Congestive Renal Failure Market By Product Type (Therapeutics, Dialysis Systems, Diagnostics & Monitoring Devices); By Application (Chronic Management, Acute Intervention); By End User (Hospitals, Specialty Renal Centers, Ambulatory & Outpatient Clinics, Home Healthcare, Research & Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Congestive Renal Failure Market is poised to witness a robust CAGR of 7.2 %, valued at around USD 12.6 billion in 2024 , and expected to ... Read More

Published Date: JAN-2026 | No Of Pages:190 | $ 4485

Chronic Ocular Surface Pain Market By Pain Mechanism (Nociceptive, Neuropathic); By Therapeutic Class (Anti-Inflammatories, Neuropathic Modulators, TRP/Sodium Channel Blockers, Regenerative Therapies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Chronic Ocular Surface Pain Market is estimated to be worth USD 1.1 billion in 2024 , with expectations to reach USD 1.75 billion by 2030 , expanding at a steady C... Read More

Published Date: JAN-2026 | No Of Pages:160 | $ 4485

Focal Segmental Glomerulosclerosis Market By Treatment Type (Corticosteroids, Calcineurin Inhibitors, Monoclonal Antibodies, Endothelin Receptor Antagonists, Emerging Biologics); By Route of Administration (Oral, Intravenous, Subcutaneous); By End User (Hospitals, Nephrology Clinics, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Focal Segmental Glomerulosclerosis Market valued at USD 2.2 billion in 2024 and projected to reach USD 3.1 billion by 2030 at 6.1% CAGR, driven by Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Membranous Nephropathy Market By Treatment Type (Pharmacological [Immunosuppressants, Biologics], Non-Pharmacological [Dialysis, Plasma Exchange, Transplant]); By Diagnostic Modality (Renal Biopsy, Urine & Blood Tests, Biomarker-Based Tests, Imaging); By End User (Hospitals, Nephrology Clinics, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Membranous Nephropathy Market projected to reach USD 2.3 billion by 2030 from USD 1.5 billion in 2024, registering 8.4% CAGR, supported by renal d... Read More

Published Date: JAN-2026 | No Of Pages:188 | $ 4485

Impetigo Treatment Market By Treatment Type (Topical Antibiotics, Oral Antibiotics, Non-Antibiotic Topicals, Adjunctive Therapies); By Route of Administration (Topical, Oral); By Distribution Channel (Retail Pharmacies & Drugstores, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Impetigo Treatment Market will witness a steady CAGR of 5.8%, valued at around USD 1.5 billion in 2024, and projected to cross USD 2.1 billion by 2030, co... Read More

Published Date: JAN-2026 | No Of Pages:157 | $ 4485

Ashermans Syndrome Market By Treatment Type (Hysteroscopic Adhesiolysis, Hormonal Therapy, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Asherman’s Syndrome Market will witness a steady CAGR of 7.2 %, valued at USD 1.2 billion in 2024,Read More

Published Date: JAN-2026 | No Of Pages:178 | $ 4485

Urinary Retention Therapeutics Market By Treatment Type (Pharmacological, Minimally Invasive, Surgical); By Application (Benign Prostatic Hyperplasia, Neurogenic Bladder, Others); By End User (Hospitals, Specialty Clinics, Outpatient Centers, Home Care); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Urinary Retention Therapeutics Market is expected to witness a robust growth trajectory, with a Compound Annual Growth Rate (CAGR) of approximately 5.6% from 2024 to 2030.... Read More

Published Date: JAN-2026 | No Of Pages:187 | $ 4485

5-Alpha Reductase Deficiency Market By Diagnostic Type (Genetic Testing, Hormonal Assays, Imaging and Physical Evaluation); By Treatment Type (Hormone Replacement Therapy, Surgical Interventions, Psychological and Gender Support Services); By End User (Pediatric Hospitals and Specialty Clinics, Genetic Testing Laboratories, Research Institutes, Endocrinology and Urology Practices); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global 5-Alpha Reductase Deficiency Market is on track for steady growth, with an estimated value of USD 412.5 million in 2024 and a projected market size of USD 657.8 million by 2030Read More

Published Date: JAN-2026 | No Of Pages:183 | $ 4485

Gynandroblastoma Market By Tumor Subtype (Granulosa-Predominant Mixed Tumors, Sertoli-Leydig-Predominant Mixed Tumors, DICER1-Associated Mixed Tumors, Other Rare Mixed Sex Cord–Stromal Tumors); By Diagnostic Approach (Histopathology and Central Pathology Review, Immunohistochemistry, Molecular Profiling, Germline DICER1 Testing and Genetic Counseling); By Treatment Modality (Surgery, Observation and Long-Term Surveillance, Chemotherapy, Hormonal and Other Recurrent-Disease Therapy); By End User (Tertiary Cancer Centers, Regional Hospitals, Diagnostic and Reference Laboratories, Women’s Health and Fertility Clinics, Genetics Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Gynandroblastoma Market: Rare-Case Care Pathway, Precision Pathology, and Long-Term Surveillance

The Global Gynandroblastoma Market is valued at USD 154.5 million in 2025 and is projected to reach USD 229.7 million by 2032, expanding at a CAGR of 5.83%, according to S... Read More

Published Date: JUL-2026 | No Of Pages:188 | $ 4485

Brain Abscess Treatment Market By Treatment Type (Antibacterial Drugs, Antifungal Drugs, Antiparasitic Drugs, Neurosurgical Treatment [Needle Aspiration, Surgical Excision]); By Route of Administration (Intravenous, Oral); By Application (Bacterial Brain Abscess, Fungal Brain Abscess, Parasitic Brain Abscess); By End User (Hospitals and Tertiary Care Centers, Neurosurgical Centers, Specialty Clinics, Outpatient Infusion and Home Healthcare Providers); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Segment Revenue Estimation, Forecast, 2026–2032

Brain Abscess Treatment Market: Emergency Care, Prolonged Therapy, and Neurosurgical Demand Sustain Hospital Revenue

The Global Brain Abscess Treatment Market was valued at USD 2.22 billion in 2025 and is projected to reach USD 3.32 billion by 2032, growing at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:199 | $ 4485

Orchiectomy Market By Procedure Type (Simple Orchiectomy, Subcapsular Orchiectomy, Radical Orchiectomy); By Application (Oncology, Gender-Affirming Surgery, Trauma, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orchiectomy Market is set to grow steadily between 2024 and 2030. It is valued at USD 476 million in 2024 and projected to reach nearly USD 713 million by 2030, advancing ... Read More

Published Date: JAN-2026 | No Of Pages:159 | $ 4485

Small Lymphocytic Lymphoma Market By Treatment Type (Targeted Therapies, Monoclonal Antibodies, Chemotherapy and Chemoimmunotherapy, CAR-T and Emerging Immunotherapies, Supportive Care); By Route of Administration (Oral, Intravenous); By Treatment Line (Watchful Waiting and Monitoring, First-Line Treatment, Second-Line Treatment, Third-Line and Later Treatment); By End User/Care Setting (Hospitals, Specialty Clinics, Outpatient Oncology Centres, Diagnostic and Molecular Testing Laboratories); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Small Lymphocytic Lymphoma Market: Long Disease Duration Expands the Commercial Care Window

The Global Small Lymphocytic Lymphoma (SLL) Market is valued at USD 3.70 billion in 2025 and is projected to reach USD 5.63 billion by 2032, expanding at a CAGR of 6.2%, accord... Read More

Published Date: JUL-2026 | No Of Pages:151 | $ 4485

Galactosemia Treatment Market By Treatment Type (Dietary Management, Pharmacological Interventions, Enzyme Replacement Therapy, Gene Therapy); By Patient Type (Infants, Adolescents, Adults); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Galactosemia Treatment Market valued at USD 0.42 billion in 2024 and projected to reach USD 0.65 billion by 2030 at 6.5% CAGR, driven by rare dise... Read More

Published Date: JAN-2026 | No Of Pages:163 | $ 4485

Aromatase Deficiency Market By Therapy Type (Estrogen Replacement Therapy, Combination Hormone Therapy, Gene Therapy and Novel Endocrine Modulators); By Route of Administration (Oral, Transdermal, Injectable); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aromatase Deficiency Market will witness a steady CAGR of 6.8%, valued at USD 423 million in 2024, and is expected to reach USD 628 million by 2030, accor... Read More

Published Date: JAN-2026 | No Of Pages:167 | $ 4485

Medication-Assisted Treatment Market By Drug Type (Buprenorphine, Methadone, Naltrexone, Others); By Route of Administration (Oral, Sublingual, Injectable, Implantable); By Application (Opioid Use Disorder, Alcohol Use Disorder, Other Substance Use Disorders); By End User (Specialty Addiction Treatment Centers, Hospitals & Clinics, Telehealth Platforms, Correctional Facilities, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Medication-Assisted Treatment Market is poised for substantial expansion, projected to grow at a CAGR of 6.9% between 2024 and 2030. The market is currently valued at USD 4.7 billi... Read More

Published Date: JAN-2026 | No Of Pages:189 | $ 4485

Severe Hypertriglyceridemia Treatment Market By Drug Class (Fibrates, Omega-3 Derivatives, Statins, Niacin, Emerging Biologics); By Route of Administration (Oral, Injectable); By End User (Hospitals & Specialty Clinics, Retail & Hospital Pharmacies, Research & Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Severe Hypertriglyceridemia Treatment Market is projected to grow at a CAGR of 8.1%, valued at approximately USD 2.6 billion in 2024, and... Read More

Published Date: JAN-2026 | No Of Pages:173 | $ 4485

Thrombocythemia Market By Treatment Type (Cytoreductive Therapy, Targeted Therapies, Antiplatelet Agents, Stem Cell Transplant and Experimental Therapies); By Diagnostic Method (Complete Blood Count, Bone Marrow Biopsy, Molecular Testing); By End User (Hospitals & Specialty Hematology Centers, Diagnostic Laboratories, Retail & Online Pharmacies); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thrombocythemia Market is projected to expand steadily, growing at an estimated CAGR of 6.1%, valued at USD 1.9 billion in 2024 and expec... Read More

Published Date: JAN-2026 | No Of Pages:197 | $ 4485

Amnestic Disorders Therapeutics Market By Drug Class (Cholinesterase Inhibitors, NMDA Receptor Antagonists, GABA Modulators, Neuroregenerative Agents); By Route of Administration (Oral, Injectable, Transdermal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Amnestic Disorders Therapeutics Market is projected to grow at a steady pace, with an estimated value of $4.8 billion in 2024, expected to reach around $7.2 billion by 2030Read More

Published Date: JAN-2026 | No Of Pages:150 | $ 4485